US Stocks Tumble as Oil Tops $100, Tech Sells Off on Alphabet and Tesla Warnings

Oil Surge and Tech Woes Trigger Broad Sell-Off

US equities suffered a sharp, broad-based sell-off on Thursday as a cocktail of geopolitical tension, commodity spikes and technology disappointments overwhelmed markets. The S&P 500 fell 1.2%, while the tech-heavy Nasdaq registered even steeper losses, dragging indices to one of their worst sessions in weeks. The decline was not a single-story event but a simultaneous collision of three powerful forces: an oil shock that revived inflation anxiety, a jump in Treasury yields that re-priced rate expectations, and earnings signals from two of the market’s biggest names that shook confidence in the growth story.

The catalyst for the energy surge came from the Red Sea. Iran-backed Houthi forces announced they had targeted two Saudi oil tankers, an attack that coincided with a blunt warning from President Trump on Truth Social. He threatened to strike critical infrastructure inside Iran if any vessel in the Strait of Hormuz was attacked again with missiles or drones. The immediate result: Brent crude futures settled at $100.69 a barrel, up 7% on the day, after briefly trading above $101. For a market already anxious about sticky inflation, the move was significant. The yield on the 10-year US Treasury note climbed past 4.7%, a level not seen since January 2025, and fed funds futures now imply an 82% probability of a rate hike at the September Federal Reserve meeting, up from just 52% a week ago.

Amid the macro turmoil, Alphabet and Tesla delivered company-specific shocks. Alphabet, the parent of Google, raised its 2026 capital expenditure forecast to a range of $195–205 billion, up from a previous estimate of $180–190 billion. While management framed the increase as a response to robust demand for cloud and AI services, investors recoiled at the sheer scale of spending, worrying that return on such enormous outlays remains distant. Tesla’s report was even more punitive: the company swung to negative free cash flow in the second quarter, eroding confidence in its margin resilience. Together, the two names dragged the entire mega-cap technology complex lower, with Microsoft, Meta and Amazon all suffering meaningful losses. Defensive and counter-cyclical sectors provided the only real shelter. Lockheed Martin jumped 11% after posting better-than-expected quarterly earnings of $7.94 per share on $20.06 billion in revenue and lifting full-year guidance. Eli Lilly advanced 1% after successful late-stage trials of a new obesity drug, with a regulatory filing planned for early 2027.

How Geopolitics, AI Spending and Rate Fears Converged on One Day

The Oil Shock: Middle East Escalation Hits a Market Already Nervous About Inflation

The Houthi attack on Saudi tankers, followed by Trump’s explicit threat to strike Iranian infrastructure, represents a sharp escalation in a region that handles roughly a third of the world’s seaborne oil trade. Unlike previous skirmishes that produced brief price spikes, this episode pushed Brent decisively above the psychologically important $100 level and did so on a day when bond markets were already tightening. The linkage is direct: sustained oil above $100 feeds into headline inflation, erodes consumer spending power, and complicates the Federal Reserve’s path. The rapid re-pricing of September rate-hike odds, from a coin toss to a near certainty in one week, shows that markets are engaging with the possibility that the central bank has not yet tamed inflation and may be forced to tighten further precisely when growth is showing cracks.

Alphabet’s AI Splurge Reopens the Capex Debate

Alphabet’s decision to lift 2026 capex guidance by up to $25 billion is a bet that demand for AI and cloud computing will remain insatiable. The market, however, is beginning to question whether the hyperscalers can earn adequate returns on investments of this magnitude. The spending forecast now equals roughly the annual GDP of a mid-sized country, yet there is still limited visibility on when those outlays translate into proportionate incremental revenue. Investors are worried not just about Alphabet but about the entire AI ecosystem: if the largest and most efficient firms need to spend this much, smaller rivals face an even steeper climb. That concern spilled into Meta, Amazon and Microsoft, all of which are committed to their own massive AI budgets. Rising bond yields compound the pressure because they raise the discount rate applied to future cash flows, hitting long-duration growth stories hardest.

Tesla’s Cash Flow Warning Squeezes Growth Valuations

Tesla’s shift to negative free cash flow was a wake-up call for shareholders who had grown accustomed to the narrative of self-funding expansion. It arrives at a time when competition in electric vehicles is intensifying globally and price cuts have been needed to sustain demand. The combination of shrinking margins and cash burn leaves less room for error and makes the stock more sensitive to any further increase in financing costs. Because Tesla is often seen as the bellwether for speculative growth, its troubles fed directly into the broader tech sell-off, reinforcing the rotation away from high-multiple names that had already been triggered by the move in yields.

The Fed’s Inflation Headache Is Worse Than It Looked a Week Ago

Just days before this sell-off, market consensus was still gravitating toward a soft landing with only limited additional tightening. The combination of an oil-driven inflation impulse and a bond yield breakout changes that calculus. If Brent sustains above $100 and the geopolitical situation worsens, the Fed may face a genuine dilemma: tighten into an energy-induced inflation scare and risk a harder landing, or pause and risk letting expectations unanchor again. The probability shift to 82% for a September hike is not just a mechanical reaction to higher oil; it reflects a broader reassessment that inflation’s decline could stall well above target, keeping the terminal rate higher for longer.

Rare Bright Spots: Defense and Pharma Buck the Trend

Lockheed Martin’s 11% surge and Eli Lilly’s modest gain highlight that even on days of heavy selling, sector rotation is highly selective. Lockheed is a direct beneficiary of elevated geopolitical risk: increased military spending, missile defense needs, and potential for further US engagement in the Middle East all support its order book. The company’s decision to raise full-year guidance after a strong quarter reinforced that defense stands as a rare bull trend in a risk-off tape. Eli Lilly’s advance is less about geopolitics and more about a standalone drug development catalyst. Success in late-stage obesity trials and a clear regulatory timeline provide a counterweight to the risk-off mood, especially as demand for weight-loss treatments remains one of the most powerful secular themes in healthcare.

What This Means for Positioning and Risks

The day’s events create a different risk map than the one investors were working with at the start of July. The key shifts to act on are:

• Re-evaluate exposure to long-duration tech names. With the 10-year yield above 4.7% and the probability of a September Fed hike now at 82%, the valuation premium for growth stocks is being compressed rapidly. Alphabet and Tesla have already demonstrated how specific earnings vulnerabilities can amplify that pressure.
• Track Brent crude’s ability to hold above $100. A sustained move there would directly affect US CPI readings within two months, keeping the Fed in tightening mode and potentially pushing the terminal rate higher. Energy sector equities, which have lagged the commodity itself, may catch up if the geopolitical risk premium persists.
• Watch the Strait of Hormuz developments for second-order effects on shipping insurance, freight rates, and broader supply chains. Trump’s threat to target Iranian infrastructure changes the stakes. Any further Houthi attacks or US retaliation will inject another round of price spikes across commodities and could trigger risk-off deleveraging across portfolios.
• Position for divergence within technology. Alphabet’s ballooning capex numbers mean that the AI investment cycle will continue to reward semiconductor and infrastructure providers even as the platform stocks themselves face multiple compression. The sell-off in Microsoft, Meta and Amazon may not be uniform once second-quarter earnings clarify individual spending trajectories.
• Defense and pharma are offering protection that is rooted in specific catalysts, not just defensive rotation. Lockheed Martin’s guidance raise and Eli Lilly’s obesity drug milestone are not yet fully priced in, but the window will narrow as more investors pile into them for shelter.